Molecular Diagnosis in Children With Febrile Seizures: Beyond the Conventional Clinical Classification
Molekulare Diagnose bei Kindern mit febrilen Anfällen: über die konventionelle klinische Klassifikation hinaus
Annals of Clinical and Translational Neurology · 06.11.2026
DOI: 10.1002/acn3.70572 ↗Auf einen Blick
Bei 2552 Kindern mit febrilen Anfällen ergab die Molekulardiagnostik in 11 % eine positive Diagnose. Zwischen einfachen und komplexen febrilen Anfällen zeigte sich kein signifikanter Unterschied.
Fragestellung
Kann eine molekulare Diagnostik die konventionelle klinische Klassifikation bei febrilen Anfällen ergänzen und die Diagnose verbessern?
Methode
Nationwide, multizentrische prospektive Kohortenstudie von Januar 2019 bis Februar 2023; Panel mit 189 Genen; Einteilung in SFS und CFS; Varianteneinstufung nach ACMG.
Ergebnisse
3300 Kinder mit FS eingeschlossen, Sequenzdaten von 2552 analysiert, 273 positive Diagnosen. Diagnostische Ausbeute 11 % (273/2552); SFS 9,5 % (111/1163) vs. CFS 11,7 % (162/1389), p = 0,085. Klinischer Nutzen: Management 76,2 %, Prognose 72,6 %.
Schlussfolgerung der Autor:innen
Die molekulare Diagnose kann die Diagnose von FS verbessern, indem genetische fiebersensitive Epilepsien erkannt werden, die bei phänotypischer Klassifikation übersehen werden können.
Kernaussagen
- Molekulare Diagnostik: 11 % positive Diagnose
- Kein signifikanter Unterschied zwischen SFS und CFS
- Klinischer Nutzen bei Management und Prognose
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 06.11.2026. Verfasst von Jia Wang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Capital Center for Children's Health, Capital Medical University, Beijing, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Innovation Talent Fund of Senior Department of Pediatrics, The Seventh Medical Center of PLA General Hospital.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Febrile seizures (FS) are currently classified as simple or complex primarily to describe seizure characteristics, with limited ability to identify the underlying etiology. We evaluated whether molecular diagnosis could complement conventional classification and improve the diagnosis and management of FS.
Methods
This nationwide, multi‐center, prospective cohort study, conducted from January 2019 to February 2023, enrolled patients who were clinically diagnosed with FS. The panel targeted 189 genes associated with fever‐induced seizures. Initially, children were categorized into simple febrile seizures (SFS) and complex febrile seizures (CFS) groups based on medical history and clinical evaluation. Variant classification followed the ACMG guidelines. We analyzed the cohort demographic characteristics, potential genetic etiologies across different clinical phenotypes, and clinical utility of genetic diagnosis.
Results
Our study included 3300 children with FS, and ultimately analyzed sequencing data from 2552 children, of whom 273 received a positive diagnosis. The molecular diagnostic yield was 11% (273 out of 2552 patients), with the top 10 genes accounting for 70.4% of all confirmed genetic diagnoses. No significant difference in molecular diagnostic yield was observed between the SFS (9.5%, 111/1163) and CFS (11.7%, 162/1389) groups ( p = 0.085). Molecular diagnostics had immediate clinical utility, influencing management (76.2%) and informing prognosis (72.6%). The cost of a single panel sequencing for a three‐person family was $240, with a turnaround time of 14 days.
Interpretation
Molecular diagnosis may improve the diagnosis of FS by identifying genetic fever‐sensitive epilepsies that may be missed by phenotype‐based classification, with implications for risk stratification and individualized management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Capital Center for Children's Health, Capital Medical University, Beijing, China.
- Senior Department of Pediatrics, The First Medical Center of PLA General Hospital, Beijing, China.
- Molecular Diagnosis Center, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
- Department of Neurology, Hebei Children's Hospital, Shijiazhuang, Hebei, China.
- Department of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Neurology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Sanqing Xu, Yanli Ma, Liping Zou
Förderung
- National Key Research and Development Program of China
- Innovation Talent Fund of Senior Department of Pediatrics, The Seventh Medical Center of PLA General Hospital
Zitieren
APA
Wang, J., Zhang, M., Wang, Y., Shi, X., Li, B., Wang, X., Sun, D., Xu, S., Zhao, J., Du, L., Pang, Q., Liu, X., Tang, C., Li, X., Li, J., Ma, Y., Liao, J., Abudureyimu, G., Liang, J., …, & Zou, L. (2026). Molecular Diagnosis in Children With Febrile Seizures: Beyond the Conventional Clinical Classification. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70572
Vancouver
Wang J, Zhang M, Wang Y, Shi X, Li B, Wang X, et al. Molecular Diagnosis in Children With Febrile Seizures: Beyond the Conventional Clinical Classification. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70572
BibTeX
@article{Wang2026,
author = {Wang, Jia and Zhang, Mengna and Wang, Yangyang and Shi, Xiuyu and Li, Baoguang and Wang, Xiuxia and Sun, Dan and Xu, Sanqing and Zhao, Jianbo and Du, Lijun and Pang, Qiming and Liu, Xiaoming and Tang, Chunhui and Li, Xiaohua and Li, Jiuwei and Ma, Yanli and Liao, Jianxiang and Abudureyimu, Gulixian and Liang, Jianmin and Wang, Yuan and Wu, De and Wu, Jian and Zou, Liping},
title = {Molecular Diagnosis in Children With Febrile Seizures: Beyond the Conventional Clinical Classification},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70572}
}
EUVIMED